These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37424900)

  • 21. [Impact of dynamic changes of waist circumference and body mass index on type 2 diabetes mellitus risk].
    Chen F; Guo Z; Wu M; Zhou Z; Luo W
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Dec; 49(12):1092-7. PubMed ID: 26887305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.
    Taniguchi H; Nirengi S; Ishihara K; Sakane N
    PLoS One; 2022; 17(2):e0263774. PubMed ID: 35192641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haptoglobin levels are influenced by Hp1-Hp2 polymorphism, obesity, inflammation, and hypertension in type 2 diabetes mellitus.
    Rodrigues KF; Pietrani NT; Carvalho LML; Bosco AA; Sandrim VC; Ferreira CN; Gomes KB
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):99-107. PubMed ID: 30528492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease.
    Gómez-Sámano MÁ; Vargas-Abonce VP; Martínez-Sánchez FD; Palacios-Báez L; Vera-Zertuche JM; Navarro-Flores MF; Morales-García MG; Fonseca-Correa JI; Zuarth-Vázquez JM; Vega-Vega O; Correa-Rotter R; Rincón-Pedrero R; Morales-Buenrostro LE; Alberú-Gómez J; Ramírez-González JB; Pacheco-Domínguez RL; López-Cervantes M; Mendoza-de-la-Garza MLÁ; Baeza-Arias YV; Espinosa-Cuevas Á; López-Carrasco G; López-Estrada A; Guillén-Pineda LE; Gómez-Pérez FJ; Cuevas-Ramos D
    Ther Adv Endocrinol Metab; 2021; 12():20420188211001160. PubMed ID: 33854753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
    Barb D; Bril F; Kalavalapalli S; Cusi K
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3327-3336. PubMed ID: 30848827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status.
    Lee Y; Lim S; Hong ES; Kim JH; Moon MK; Chun EJ; Choi SI; Kim YB; Park YJ; Park KS; Jang HC; Choi SH
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):57-64. PubMed ID: 23278761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
    Cuevas-Ramos D; Almeda-Valdes P; Gómez-Pérez FJ; Meza-Arana CE; Cruz-Bautista I; Arellano-Campos O; Navarrete-López M; Aguilar-Salinas CA
    Eur J Endocrinol; 2010 Sep; 163(3):469-77. PubMed ID: 20566587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.
    Chow WS; Xu A; Woo YC; Tso AW; Cheung SC; Fong CH; Tse HF; Chau MT; Cheung BM; Lam KS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2454-9. PubMed ID: 23887638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes.
    Eto K; Tumenbayar B; Nagashima S; Tazoe F; Miyamoto M; Takahashi M; Ando A; Okada K; Yagyu H; Ishibashi S
    Diabetes Res Clin Pract; 2010 Jul; 89(1):52-7. PubMed ID: 20452080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history.
    Wang D; Zhu W; Li J; An C; Wang Z
    PLoS One; 2013; 8(11):e81190. PubMed ID: 24260557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes.
    Berti L; Irmler M; Zdichavsky M; Meile T; Böhm A; Stefan N; Fritsche A; Beckers J; Königsrainer A; Häring HU; de Angelis MH; Staiger H
    Mol Metab; 2015 Jul; 4(7):519-27. PubMed ID: 26137439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SERUM LEVELS OF FIBROBLAST GROWTH FACTOR 21 IN TYPE 2 DIABETIC PATIENTS.
    Panahi Y; Bonakdaran S; Yaghoubi MA; Keramati MR; Haratian M; Sahebkar A
    Acta Endocrinol (Buchar); 2016; 12(3):257-261. PubMed ID: 31149098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of left ventricular hypertrophy associated with type-2 diabetes in Shiraz, Iran: a cross-sectional study.
    Parsa N; Moheb M; Zibaeenezhad MJ; Karimi-Akhormeh A; Trevisan M; Wallin L; Zaheri PM; Sayadi M; Razeghian-Jahromi I; Moaref A
    BMC Cardiovasc Disord; 2023 Feb; 23(1):88. PubMed ID: 36792995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus.
    Lee CH; Woo YC; Chow WS; Cheung CYY; Fong CHY; Yuen MMA; Xu A; Tse HF; Lam KSL
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.
    Xiao Y; Xu A; Law LS; Chen C; Li H; Li X; Yang L; Liu S; Zhou Z; Lam KS
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E54-8. PubMed ID: 22013098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Madej P; Wdowczyk M; Owczarek A; Chudek J
    Eur J Endocrinol; 2015 Feb; 172(2):173-9. PubMed ID: 25411238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.
    Xiao Y; Liu L; Xu A; Zhou P; Long Z; Tu Y; Chen X; Tang W; Huang G; Zhou Z
    Cardiovasc Diabetol; 2015 Jun; 14():72. PubMed ID: 26047614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiposity phenotypes are associated with type-2 diabetes: LAP index, body adiposity index, and neck circumference.
    Marcadenti A; Fuchs FD; Moreira LB; Gus M; Fuchs SC
    Atherosclerosis; 2017 Nov; 266():145-150. PubMed ID: 29028482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic change of serum FGF21 levels in response to glucose challenge in human.
    Lin Z; Gong Q; Wu C; Yu J; Lu T; Pan X; Lin S; Li X
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1224-8. PubMed ID: 22539584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.